维普期刊资源整合服务平台（V6.5）

30篇 您的检索式：作者名="KIRKPATRICK CM"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia显示文摘	Atcheson BA Taylor P J Kirkpatrick CM	2004	Ther Drug Monit2004，26，3：	1
2	Resveratrol - pills to replace a healthy diet? 显示文摘	Chachay VS Kirkpatrick CM Hickman IJ	2011	Br J Clin Pharmacol2011，72，1：	1
3	The therapeutic monitoring of antimicrobial agents显示文摘	BEGG E J BARCLAY ML KIRKPATRICK CM	1999	Br J Clin Pharmacol1999，47，1：	1
4	Beta- lactam allergy in adults with cystic fibrosis显示文摘	BURROW JA NISSEN LM KIRKPATRICK CM et td	2007	J Cyst Fibros2007，6，4：	1
5	Monte Carlo simula- tions : maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patients 显示文摘	Roberts JA Kirkpatrick CM Lipman J	2011	J Antimicrob Chemother2011，66，2：	1
6	The therapeutic monitoring of an-timicrobial agents显示文摘	Barclay ML Kirkpatrick CM	2001	Br J Clin Pharmacol2001，，1：	1
7	Meropenem dosing in critically ill patients with sepsis and without renal dysfunction:intermittent bolus versuscontinuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution显示文摘	Roberts JA Kirkpatrick CM Roberts MS		0，，：	1
8	First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis显示文摘	Roberts JA Kirkpatrick CM Roberts MS	2010	Int J Antimicrob Agents2010，35，2：	1
9	Competitive inhibition of renal tubular secretion of gemifloxa- cin by probenecid 显示文摘	LANDERSDORFER CB KIRKPATRICK CM KINZIG M	2009	Antimicrob Agents Chemother2009，53，9：	1
10	First-dose and steady-state population pharmaeokinetics and pharmaco- dynamics of piperacillin by continuous orintermittent dosing in critically ill patients with sepsis显示文摘	Roberts JA Kirkpatrick CM Roberts MS	2010	Int J Antimicrob A- gents2010，35，2：	1
11	Current dosing of low - molecular- weight heparins does not reflect licensed product labels: an international survey 显示文摘	Barras MA Kirkpatrick CM Green B	2010	Br J Clin Pharmacol2010，69，5：	1
12	Principles and clinical application of assessing alterations in renal elimination pathways 显示文摘	Tett SE Kirkpatrick CM Gross AS	2003	Clin Pharmacokinet2003，42，：	1
13	Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia显示文摘	Atcheson BA Taylor PJ Kirkpatrick CM		0，，03：	1
14	Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia显示文摘	Atcheson BA Taylor P J Kirkpatrick CM	2004	Ther Drug Monit2004，26，3：	1
15	Holographic recording using two-photon-induced photo-polymerization显示文摘	Kirkpatrick SM Baur J W Clark CM	1999	Appl Phys A1999，69，：	1
16	Therapeutic value of orally administered silibinin in renal cell carcinoma:manipulation of insulin-like growth factor binding protein-3 levels显示文摘	Cheung CW Taylor PJ Kirkpatrick CM Vesey DA Gobe GC Winterford C	2007	BJU Int2007，100，2：	1
17	Metformin, an an- tidiahetie agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 ex- pression in human monoeytes in vitro 显示文摘	Gardiner SJ Begg EJ Kirkpatrick CM	2010	J Pharmaeol Exp Ther2010，334，1：	1
18	Transfer of Met- formin into human milk 显示文摘	Gardiner SJ Kirkpatrick CM Begg E J	2003	Clin Pharmaol Ther2003，73，1：	1
19	First dose and steady-state population pharmacokinetics and pharmaco- dynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis 显示文摘	ROBERTS JA KIRKPATRICK CM ROBERTS MS	2010	Int J Antimicrob Agents2010，35，2：	1
20	First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis显示文摘	Roberts JA Kirkpatrick CM Roberts MS	2010	Int J Antimicrob Agents2010，35，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示